Login

Andrew Sudholz, CEO, Japara Healthcare Ltd 00:00:00

Share On Facebook Share On Twitter

Andrew Sudholz, CEO, Japara Healthcare Ltd

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Nikolaj Sørensen, CEO, Orexo
00:10:00
Strategic Growth and Innovations Propel Cannabis Industry Success | Miguel Martin, CEO, Aurora Cannabis Inc.
00:10:00
Adapting Portfolio Strategy and Economic Outlook: Insights from a Real Estate CEO | Roger Waesche Jr., CEO, Corporate Office Properties Trust.
00:10:00
"Exploring Origination Platforms: Insights from Apollo Global Management's Investor Day 2021"
00:10:00
Invests in entrepreneures that are disrupting the consumer space|Assia Grazioli,Co-founder and Partner,Muse Capital
00:10:00
Chairman and CEO of CITIC Capital Discusses China's Economic Strategy and Growth Outlook | Yichen Zhang, CEO , CITIC Capital Holding.
00:10:00
Mastering the Art of Budgeting: Step 3 in 5 Vital Financial Moves | Wakefield Hare - Financial Planner, Greater Than Financial
00:10:00
4GLOBAL focused on transition after "very good" 2022 | Eloy Mazon, CEO, 4Global PLC4GBL:LSE
00:10:00
Try to build great businesses and deliver strong returns to investors|Wong Teek Son,Executive Chairman,Riverstone Holdings
00:10:00
Mr. Zelter on Apollo Global Management's Credit Strategy: High-Yield Nearing 10% Seen as 'Attractive'"
00:10:00
MFS President Carol Geremia on the Impact of Diversity and Inclusion in Building Strong Culture
00:10:00
O3 Mining: Advancing Valdor Assets Toward Production with Strong ESG Commitment

© 2026 Nehu